# Early Lyme Disease as Manifested by Erythema Migrans:  Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/early-lyme-disease-as-manifested-by-erythema-migrans-developing-drugs-for-treatment/59e6ea32-f774-48d5-8d7a-10fc9065ebd0

> FDA guidance document: Early Lyme Disease as Manifested by Erythema Migrans:  Developing Drugs for Treatment. Issue date: June 26, 2025. Get complete insights and analysis.

---

## Details

- Title: Early Lyme Disease as Manifested by Erythema Migrans:  Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-06-26
- Last Changed: 2025-07-09
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-2315">FDA-2022-D-2315</a>

## Related Documents

- [Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/eosinophilic-esophagitis-developing-drugs-for-treatment-guidance-for-industry/e454ac25-939f-4e9c-a8f1-b2613feff0b3)
- [Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/uncomplicated-urinary-tract-infections-developing-drugs-for-treatment-guidance-for-industry/c70a4ac7-4c57-4214-9174-25145ed55675)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)